Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| I-SPY-RCT — Intervention for Sleep and Pain in Youth: A Randomized Co… NCT04936321 · NCT04936321 | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | Insomnia is a common comorbidity among adolescents with migraine. This ran… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Prasugrel 5mg NCT07629635 · COMFORT-PFO — Migraine Headaches Elimination With Patent Foramen Ovale-Directed… | Migraine | À vérifier | Phase 3 | NOT_YET_RECRUITING | Migraine is a common and often disabling condition, but its exact causes a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Rimegepant NCT06616194 · A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With… | Migraine | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Rimegepant NCT05156398 · Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai… | Migraine | À vérifier | Phase 3 | RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Yogabased Movements for Primary Headaches (Migraine and/or Cluster He… NCT07348783 · NCT07348783 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | RECRUITING | Brief Summary: Migraine and/or Cluster Headache: Study Overview \*\*Backgr… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Yogabased Movements for Primary Headaches (Migraine and/or Cluster He… NCT07292090 · NCT07292090 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | ACTIVE_NOT_RECRUITING | Migraine and/or Cluster Headache: Study Overview \*\*Background:\*\* Migra… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Amitriptyline NCT05889624 · Responding With Evidence and Access for Childhood Headaches | Migraine | À vérifier | Non applicable | RECRUITING | This comparative effectiveness study will clarify current first-line preve… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| A Study of Wearable Devices to Predict Migraines NCT05755945 · NCT05755945 | Migraine | À vérifier | Non applicable | ACTIVE_NOT_RECRUITING | The purpose of this research is to determine if data from smart devices, i… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Botulinum toxin type A NCT04069897 · MiBlock — Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Trea… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| CAVA Device NCT04026516 · CAVA: Dizziness Trial | Migraine | À vérifier | Non applicable | COMPLETED | Clinical investigation of a medical device (CAVA) for recording eye moveme… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Elismetrep NCT07645924 · A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute T… | Migraine | À vérifier | Phase 3 | RECRUITING | This is a long-term safety study to evaluate the safety and tolerability o… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| EVO756, Dose 1 NCT07616128 · Study of EVO756 in Adults With Migraine | Migraine | À vérifier | Phase 2 | RECRUITING | This study will evaluate the efficacy and safety of EVO756 against placebo… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Galcanezumab NCT06085144 · Emgality for Migraine in Breastmilk | Migraine | À vérifier | À vérifier | RECRUITING | The main purpose of this study is to evaluate the efficacy of the study dr… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Headache Ear Auditory Dizziness Sinus (HEADS) Registry NCT07754266 · NCT07754266 | Migraine | Traitement symptomatique | À vérifier | RECRUITING | The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a study… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| HEADS-UP — Headache Education and Awareness vs. Daily Mindfulness Str… NCT07513662 · NCT07513662 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | NOT_YET_RECRUITING | The goal of this study (supported by and included in the NIH HEAL Initiati… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Melatonin NCT07743255 · Preventive Role of Melatonin and Propranolol Administration in Pediatric Migraine | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | Non applicable | ENROLLING_BY_INVITATION | This randomized controlled trial evaluated whether adding melatonin to pro… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| PRIMUS NCT06450444 · The RECLAIM Study. | Migraine | À vérifier | Non applicable | RECRUITING | The purpose of this study is to evaluate the safety and performance, inclu… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Rimegepant NCT07751497 · VERIFY — A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Pre… | Migraine | À vérifier | Phase 2 | NOT_YET_RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Rimegepant (PF-07899801) NCT04743141 · Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme… | Migraine | À vérifier | Phase 3 | RECRUITING | The purpose of this study is to test the long-term safety of rimegepant in… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Transcranial Direct Current stimulation NCT07743814 · EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR… | Migraine | Traitement symptomatique | Phase 3 | NOT_YET_RECRUITING | Migraine is a common, heterogeneous neurological disorder affecting approx… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Children exposed to hydroxychloroquine in utero show no signs of reti… Ocular Coherence Tomography (OCT) · PMID 42203251 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Limited examinations from prior studies support the absence of retinal toxicity in infants exposed to maternal hydroxyc… | Lupus science & medicine 2026-09-14 15:36:40 | Source |
| Clinical and surgical approach to retinoschisis. Ocular Coherence Tomography (OCT) · PMID 41578616 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To summarize the recent literature on the clinical and surgical management of retinoschisis. Novel analyses of the exis… | Current opinion in ophthalmology 2026-09-14 15:36:40 | Source |
| Visual Acuity and Intraretinal Fluid as Predictive Factors for Legal… Ocular Coherence Tomography (OCT) · PMID 42088264 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Ocular coherence tomography (OCT) biomarkers have previously been able to predict low visual acuity (VA). The purpose o… | Clinical ophthalmology (Auckland, N.Z.) 2026-09-14 15:36:40 | Source |
| Investigate the differential diagnoses of recurrent benign paroxysmal… Findings Of The Video Head Impulse Test In Patients With Vestibular Migraine · PMID 41778353 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Benign paroxysmal positional vertigo (BPPV) frequently recurs, posing diagnostic challenges when distinguishing recurre… | Acta oto-laryngologica 2026-09-14 12:36:46 | Source |
| Prostatic Artery Embolization Using Ethylene Vinyl Alcohol Copolymer… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 41739171 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source This study evaluated the short-term efficacy and safety of prostatic artery embolization (PAE) using ethylene vinyl alc… | Cardiovascular and interventional radiology 2026-09-14 12:36:46 | Source |
| Sensitivity and specificity of the video head impulse test in the dia… Findings Of The Video Head Impulse Test In Patients With Vestibular Migraine · PMID 41931986 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source To estimate the proportion of patients with VM who have abnormal vHIT results and to determine the sensitivity and spec… | Brazilian journal of otorhinolaryngology 2026-09-14 12:36:46 | Source |
| Successful retrieval of ethylene vinyl alcohol (EVOH) from the left m… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 37350037 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Preoperative embolization of a juvenile nasopharyngeal angiofibroma (JNA) using ethyl vinyl alcohol (EVOH) is an effect… | Interventional neuroradiology : journal of peritherape… 2026-09-14 12:36:46 | Source |
| Safety and efficacy of newer liquid embolic agents Squid and PHIL in… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 39569607 | Migraine | À vérifier | Publication | PubMed | Voir la publication source BackgroundA wide range of liquid embolic agents has been used in endovascular treatment (EVT) of dural arteriovenous fi… | Interventional neuroradiology : journal of peritherape… 2026-09-14 12:36:45 | Source |
| Anterior segment, static and dynamic pupillography changes in patient… Pupillography · PMID 41941919 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Glaucoma is a major cause of avoidable blindness and the most common type is primary open angle glaucoma (POAG). Topica… | Photodiagnosis and photodynamic therapy 2026-09-11 23:42:15 | Source |
| Exploratory analysis of pupillography-based machine learning for asse… Pupillography · PMID 42322958 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The pupillary light reflex (PLR) is mediated by autonomic pathways, offering a potential noninvasive biomarker for Mult… | Multiple sclerosis and related disorders 2026-09-11 23:42:15 | Source |
| OpenIrisDPI: An open-source digital dual Purkinje image eye tracker f… Pupillography · PMID 41581702 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Video-based eye trackers are widely used in vision science, psychology, clinical assessment, and neurophysiology. Many… | Journal of neuroscience methods 2026-09-11 23:42:15 | Source |
| Clinical Heterogeneity in Vestibular Migraine Diagnosed Using Bárány… Videonystagmography and Vestibular Migraine · PMID 42683798 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Vestibular migraine (VM) is a common cause of episodic vertigo with heterogeneous presentations. Some VM patients show… | Journal of clinical neurology (Seoul, Korea) 2026-09-03 16:31:53 | Source |
| Hormonal Contraception and Vestibular Disorders: A Narrative Review o… Videonystagmography and Vestibular Migraine · PMID 42261458 | Migraine | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Hormonal influences on inner ear physiology are increasingly recognized, particularly in cochlear function; however, th… | Cureus 2026-09-03 16:31:53 | Source |
| Ocular Findings During Vestibular Testing in Vestibular Migraine: Sys… Videonystagmography and Vestibular Migraine · PMID 41950055 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source ImportanceVestibular migraine (VM) is diagnosed using limited consensus-based criteria and presents with symptoms that… | Journal of otolaryngology - head & neck surgery = Le J… 2026-09-03 16:31:53 | Source |
| Interaction of magnolol with bovine serum albumin: a fluorescence-que… Elismetrep (K-304) 5 mg · PMID 12830359 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The interaction of magnolol with bovine serum albumin(BSA) was studied using fluorescence spectroscopy under physiologi… | Analytical and bioanalytical chemistry 2026-09-01 09:22:47 | Source |
| Associative charge transfer reactions. Temperature effects and mechan… Elismetrep (K-304) 10 mg · PMID 16821845 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source In associative charge transfer (ACT) reactions, a core ion activates ligand molecules by partial charge transfer. The a… | The journal of physical chemistry. A 2026-09-01 09:22:45 | Source |
| Binding of dihydromyricetin to human hemoglobin: fluorescence and cir… Elismetrep (K-304) 10 mg · PMID 22465778 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The binding reaction between dihydromyricetin (DMY) and human hemoglobin (HHb) was investigated systematically with var… | Spectrochimica acta. Part A, Molecular and biomolecula… 2026-09-01 09:22:45 | Source |
| Thermodynamics, conformation and active sites of the binding of Zn-Nd… Elismetrep (K-304) 10 mg · PMID 18937061 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The interactions between N,N'-di(2-hydroxy-3-methyoxy-phenyl-1-methylene)-o-phenyldiamine-mone Zn(II), Nd(III) nitrate… | Journal of fluorescence 2026-09-01 09:22:45 | Source |
| Bergapten Attenuates Nitroglycerin-Induced Migraine Headaches through… Sumatriptan 50 mg · PMID 34455773 | Migraine | Neuroprotection · Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source The present study intended to examine the effect of bergapten and possible mechanisms involved in the treatment of migr… | ACS chemical neuroscience 2026-08-16 21:22:02 | Source |
| Onset of action in placebo-controlled migraine attacks trials: A lite… Sumatriptan 50 mg · PMID 32903063 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Migraine patients want acute treatment to provide complete relief of the migraine attack within 30 minutes. Traditional… | Cephalalgia : an international journal of headache 2026-08-16 21:22:02 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |